South Korea has granted marketing authorization to use Gilead Sciences' Veklury (remdesivir) for coronavirus treatment, reported The Korea Bizwire.
The country has already allowed the special import of the drug for emergency use since June, with the latest move expected to make it easier to secure adequate supply of the medicine going forward, the Ministry of Food and Drug Safety said.
The ministry said the latest authorization is conditional on Gilead supplying final data on the most recent clinical tests and sending production and safety control standards it is using for the production of the medicine within a set period of time.
"The latest move takes into account that Veklury has undergone extensive clinical trials in 10 countries and by 73 medical institutions, with initial reports indicating that it can reduce the hospitalization period of infected people by some 31%," the drug safety authority added.
To read more NewsPoints articles, click here.